发明名称 BIOSYNCHRONOUS TRANSDERMAL DRUG DELIVERY FOR LONGEVITY, ANTI-AGING, FATIGUE MANAGEMENT, OBESITY, WEIGHT LOSS, WEIGHT MANAGEMENT, DELIVERY OF NUTRACEUTICALS, AND THE TREATMENT OF HYPERGLYCEMIA, ALZHEIMER'S DISEASE, SLEEP DISORDERS...
摘要 Systems and methods for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and treating hyperglycemia, Alzheimer's disease, sleep disorders, Parkinson's disease, Attention Deficit Disorder and nicotine addiction involve synchronizing and tailoring the administration of nutraceuticals, medications and other substances (for example, stimulants) in accordance with the body's natural circadian rhythms, meal times and other factors. Improved control of blood glucose levels, extended alertness, and weight control, and counteracting of disease symptoms when they are at their worst are possible. An automated, pre-programmable transdermal administration system is used to provide pulsed doses of medications, pharmaceuticals, hormones, neuropeptides, anorexigens, pro-drugs, stimulants, plant extracts, botanicals, nutraceuticals, cosmeceuticals, phytochemicals, phytonutrients, enzymes, antioxidants, essential oils, fatty acids, minerals, vitamins, amino acids, coenzymes, or other physiological active ingredient or precursor. The system can utilize a pump, pressurized reservoir, a system for removing depleted carrier solution, or other modulated dispensing actuator, in conjunction with porous membranes or micro-fabricated structures.
申请公布号 US2014323423(A1) 申请公布日期 2014.10.30
申请号 US201414268725 申请日期 2014.05.02
申请人 Chrono Therapeutics, Inc. 发明人 DiPierro Guy;Giannos Steven A.
分类号 A61M35/00;A61K31/137;A61K31/165;A61K31/415;A61K31/708;A61K31/4965;A61K31/155;A61K31/473;A61K31/55;A61K31/7072;A61K31/4439;A61K31/17 主分类号 A61M35/00
代理机构 代理人
主权项 1. A method for delivering an active substance to a human or animal comprising: providing a transdermal drug delivery device coupled to the human or animal, the delivery device having a source of the active substance, a programmable timing mechanism, and a mechanism for causing the active substance to be delivered transdermally in response to the timing mechanism; and timing routines implemented by the timing mechanism, wherein the timing routines are selected to deliver the active substance at a time, rate, sequence and/or cycle that is synchronized with a biological rhythm of the human or animal.
地址 Cambridge MA US